成人维生素D缺乏筛查:USPSTF更新证据报告与系统综述
在社区居住的低维生素D水平人群中,维生素D治疗与死亡率、骨折、跌倒、抑郁、糖尿病、心血管疾病、癌症或不良事件的发生率无显著关联,对躯体功能和感染的影响证据不足。
要点
- 无研究直接评估维生素D缺乏筛查的获益或危害。
- 社区低维生素D人群治疗对死亡率、骨折、跌倒等无显著影响。
- 治疗对躯体功能和感染的影响证据不足。
核心结论
- 无研究直接评估维生素D缺乏筛查的获益或危害。
- 在无症状社区低维生素D人群中,治疗对死亡率、骨折、跌倒、抑郁、糖尿病、心血管疾病、癌症或不良事件无影响。
- 治疗对躯体功能和感染的影响证据不确定。
研究设计与样本
- 纳入标准为公平或高质量、英文随机临床试验(RCT),比较血清25-羟基维生素D(25[OH]D)筛查与不筛查,或维生素D(伴或不伴钙)治疗与安慰剂或不治疗,限于非妊娠成人。
- 仅危害结局纳入非随机对照干预研究;治疗研究限于入组或分析低血清维生素D水平的参与者。
主要发现
- 社区人群治疗与死亡率无显著关联(汇总绝对风险差[ARD] 0.3% [95% CI, -0.6% to 1.1%];8项RCT,n=2006)。
- 治疗与任何骨折无显著关联(汇总ARD -0.3% [95% CI, -2.1% to 1.6%];6项RCT,n=2186)。
- 治疗与糖尿病发病率无显著关联(汇总ARD 0.1% [95% CI, -1.3% to 1.6%];5项RCT,n=3356)。
- 治疗与心血管疾病发病率无显著关联(2项RCT;风险比1.00 [95% CI, 0.74 to 1.35]和1.09 [95% CI, 0.68 to 1.76])。
- 治疗与癌症发病率无显著关联(2项RCT;风险比0.97 [95% CI, 0.68 to 1.39]和1.01 [95% CI, 0.65 to 1.58])。
关键数值与推荐
- 跌倒发生率汇总ARD为-4.3%(95% CI, -11.6% to 2.9%;6项RCT)。
- 治疗组与对照组不良事件和肾结石发生率相似。
- 躯体功能证据混合(2项RCT),感染证据有限(1项RCT)。
临床怎么用
- 对于无症状社区低维生素D成人,现有证据不支持维生素D治疗能改善死亡率、骨折、跌倒等结局。
- 筛查维生素D缺乏的获益或危害缺乏直接证据,临床决策需结合个体情况。
局限性
- 无研究直接评估筛查的获益或危害。
- 部分结局证据有限或混合,如躯体功能和感染。
- 治疗研究限于低维生素D水平人群,可能影响普遍性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Low serum vitamin D levels have been associated with adverse clinical outcomes; identifying and treating deficiency may improve outcomes. OBJECTIVE: To review the evidence about screening for vitamin D deficiency in adults. DATA SOURCES: PubMed, EMBASE, the Cochrane Library, and trial registries through March 12, 2020; bibliographies from retrieved articles, outside experts, and surveillance of the literature through November 30, 2020. STUDY SELECTION: Fair- or good-quality, English-language randomized clinical trials (RCTs) of screening with serum 25-hydroxyvitamin D (25[OH]D) compared with no screening, or treatment with vitamin D (with or without calcium) compared with placebo or no treatment conducted in nonpregnant adults; nonrandomized controlled intervention studies for harms only. Treatment was limited to studies enrolling or analyzing participants with low serum vitamin D levels. DATA EXTRACTION AND SYNTHESIS: Two reviewers assessed titles/abstracts and full-text articles, extracted data, and assessed study quality; when at least 3 similar studies were available, meta-analyses were conducted. MAIN OUTCOMES AND MEASURES: Mortality, incident fractures, falls, diabetes, cardiovascular events, cancer, depression, physical functioning, and infection. RESULTS: Forty-six studies (N = 16 205) (77 publications) were included. No studies directly evaluated the health benefits or harms of screening. Among community-dwelling populations, treatment was not significantly associated with mortality (pooled absolute risk difference [ARD], 0.3% [95% CI, -0.6% to 1.1%]; 8 RCTs, n = 2006), any fractures (pooled ARD, -0.3% [95% CI, -2.1% to 1.6%]; 6 RCTs, n = 2186), incidence of diabetes (pooled ARD, 0.1% [95% CI, -1.3% to 1.6%]; 5 RCTs, n = 3356), incidence of cardiovascular disease (2 RCTs; hazard ratio, 1.00 [95% CI, 0.74 to 1.35] and 1.09 [95% CI, 0.68 to 1.76]), incidence of cancer (2 RCTs; hazard ratio, 0.97 [95% CI, 0.68 to 1.39] and 1.01 [95% CI, 0.65 to 1.58], or depression (3 RCTs, various measures reported). The pooled ARD for incidence of participants with 1 or more falls was -4.3% (95% CI, -11.6% to 2.9%; 6 RCTs). The evidence was mixed for the effect of treatment on physical functioning (2 RCTs) and limited for the effect on infection (1 RCT). The incidence of adverse events and kidney stones was similar between treatment and control groups. CONCLUSIONS AND RELEVANCE: No studies evaluated the direct benefits or harms of screening for vitamin D deficiency. Among asymptomatic, community-dwelling populations with low vitamin D levels, the evidence suggests that treatment with vitamin D has no effect on mortality or the incidence of fractures, falls, depression, diabetes, cardiovascular disease, cancer, or adverse events. The evidence is inconclusive about the effect of treatment on physical functioning and infection.
引用
- Kahwati LC, LeBlanc E, Weber RP, et al. Screening for Vitamin D Deficiency in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2021. PMID: 33847712. doi:10.1001/jama.2020.26498
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。